Evidence of Failed Resolution Mechanisms in Arrhythmogenic Inflammation, Fibrosis and Right Heart Disease

• Published in: Biomolecules (Basel, Switzerland) Switzerland), 2022-05, Vol.12 (5), p.720
• Main Authors: Younes, Rim, LeBlanc, Charles-Alexandre, Hiram, Roddy
• Format: Article
• Language: English
• Subjects: Arteriosclerosis; Asthma; atrial fibrillation; Cardiac arrhythmia; Cardiovascular disease; Cell activation; Chemokines; Chronic obstructive pulmonary disease; Coronary artery disease; Cytochrome; Fibrillation; Fibroblasts; Fibrosis; Granulocytes; Heart attacks; Heart diseases; Homeostasis; Hypertension; Inflammation; Inflammatory diseases; Leukocytes (neutrophilic); Lipids; Liver diseases; Macrophages; Metabolism; Metabolites; Monocytes; Myocardial infarction; Neurodegenerative diseases; Neutrophils; Permeability; Phagocytosis; Pulmonary arteries; resolution; Review; right heart disease
• ISSN: 2218-273X; 2218-273X
• DOI: 10.3390/biom12050720

Inflammation is a complex program of active processes characterized by the well-orchestrated succession of an initiation and a resolution phase aiming to promote homeostasis. When the resolution of inflammation fails, the tissue undergoes an unresolved inflammatory status which, if it remains uncontrolled, can lead to chronic inflammatory disorders due to aggravation of structural damages, development of a fibrous area, and loss of function. Various human conditions show a typical unresolved inflammatory profile. Inflammatory diseases include cancer, neurodegenerative disease, asthma, right heart disease, atherosclerosis, myocardial infarction, or atrial fibrillation. New evidence has started to emerge on the role, including pro-resolution involvement of chemical mediators in the acute phase of inflammation. Although flourishing knowledge is available about the role of specialized pro-resolving mediators in neurodegenerative diseases, atherosclerosis, obesity, or hepatic fibrosis, little is known about their efficacy to combat inflammation-associated arrhythmogenic cardiac disorders. It has been shown that resolvins, including RvD1, RvE1, or Mar1, are bioactive mediators of resolution. Resolvins can stop neutrophil activation and infiltration, stimulate monocytes polarization into anti-inflammatory-M2-macrophages, and activate macrophage phagocytosis of inflammation-debris and neutrophils to promote efferocytosis and clearance. This review aims to discuss the paradigm of failed-resolution mechanisms (FRM) potentially promoting arrhythmogenicity in right heart disease-induced inflammatory status.